TAILORED IMMUNOSUPPRESSION IN DE NOVO RENAL TRANSPLANTATION BASED ON IMMUNE FUNCTION MONITORING: A RANDOMISED CONTROLLED TRIAL

被引：0
|
作者：
Van Laecke, Steven [1 ]
Terryn, Wim [2 ]
Nagler, Evi [1 ]
Van Biesen, Wim [1 ]
Glorieux, Griet [1 ]
Schepers, Eva [1 ]
Vanholder, Raymond [1 ]
机构：
[1] Ghent Univ Hosp, Renal Div, Ghent, Belgium
[2] Jan Yperman, Renal Div, Ieper, Belgium
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP777
引用
收藏
页码：406 / 406
页数：1
相关论文
共 50 条
  • [21] Monitoring of immune function for treatment of post-transplant de novo malignancy
    Uemura, Tadahiro
    Riley, Thomas R., III
    Khan, Akhtar
    Schreibman, Ian
    Hollenbeak, Christopher
    Kwon, Osun
    Ghahramani, Nasrollah
    Reeves, Brian
    Domen, Ronald E.
    Zander, Dani S.
    Kadry, Zakiyah
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 479 - 479
  • [22] Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients
    Kirk, Allan D.
    Adams, Andrew B.
    Durrbach, Antoine
    Ford, Mandy L.
    Hildeman, David A.
    Larsen, Christian P.
    Vincenti, Flavio
    Wojciechowski, David
    Woodle, E. Steve
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 (05) : 1691 - 1698
  • [23] Mycophenolate mofetil-based immunosuppression with sirolimus in renal transplantation: a randomized, controlled Spare-the-Nephron trial
    Weir, Matthew R.
    Mulgaonkar, Shamkant
    Chan, Laurence
    Shidban, Hamid
    Waid, Thomas H.
    Preston, Dennis
    Kalil, Roberto N.
    Pearson, Thomas C.
    KIDNEY INTERNATIONAL, 2011, 79 (08) : 897 - 907
  • [24] Monitoring immunosuppression following kidney transplantation:: Experience with the Cylex™ immune cell function assay
    Swanson, J
    Hale, D
    Cendales, L
    Kirk, A
    Mannon, RB
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 370A - 370A
  • [25] De novo tacrolimus-based immunosuppression reduces renal allograft fibrosis compared to neoral:: a prospective randomized clinical trial
    Murphy, GJ
    Waller, JR
    Sandford, R
    Nicholson, ML
    BRITISH JOURNAL OF SURGERY, 2002, 89 : 7 - 7
  • [26] A randomized, controlled trial of everolimus-based dual immunosuppression versus standard of care in de novo kidney transplant recipients
    Chadban, Steven J.
    Eris, Josette Marie
    Kanellis, John
    Pilmore, Helen
    Lee, Po Chang
    Lim, Soo Kun
    Woodcock, Chad
    Kurstjens, Nicol
    Russ, Graeme
    TRANSPLANT INTERNATIONAL, 2014, 27 (03) : 302 - 311
  • [27] INTERSTITIAL FIBROSIS AND FIBROUS INTIMAL THICKENING IN DE NOVO RENAL ALLOGRAFTS UNDER SIROLIMUS OR CYCLOSPORINE: RESULTS OF A RANDOMISED, CONTROLLED TRIAL (FIBRASIC)
    Woestenburg, Annemie T.
    Peeters, Patrick
    Sennesael, Jacques
    Abramowicz, Daniel
    Wissing, Karl M.
    Geers, Caroline
    Van Marck, Eric A.
    Van Daele, Andre
    Juergens, Angelika
    De Winter, Benedicte
    Verpooten, Gert A.
    Bosmans, Jean-Louis
    TRANSPLANT INTERNATIONAL, 2009, 22 : 79 - 79
  • [28] A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation
    Watson, CJE
    Firth, J
    Williams, PF
    Bradley, JR
    Pritchard, N
    Chaudhry, A
    Smith, JC
    Palmer, CR
    Bradley, JA
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) : 2496 - 2503
  • [29] De novo mTOR inhibitor-based immunosuppression in ABO-incompatible kidney transplantation
    Koch, Martina
    Wiech, Thorsten
    Marget, Matthias
    Peine, Sven
    Thude, Hansjoerg
    Achilles, Eike G.
    Fischer, Lutz
    Lehnhardt, Anja
    Thaiss, Friedrich
    Nashan, Bjoern
    CLINICAL TRANSPLANTATION, 2015, 29 (11) : 1021 - 1028
  • [30] ISA247: A phase IIB multicenter, open label, concentration-controlled trial in de novo renal transplantation
    Gaber, A. O.
    Busque, S.
    Mulgaonkar, S.
    Gaston, R.
    Jevnikar, A.
    Meier-Kriesche, H. -U.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 336 - 336
12345